α-TEA in Advanced Cancer

Clinical trial NCT02192346 · COMPLETED

Trial details

NCT number: NCT02192346
Sponsor: Providence Health & Services
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Carcinoma Metastatic Sarcoma Metastatic Lymphoma

Start date: 2014-08-04
Primary completion: 2017-12-11
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.